Ghost Tree Capital as of Dec. 31, 2023
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 49 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Call Option (IWM) | 16.4 | $50M | 250k | 200.71 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 16.1 | $49M | 550k | 89.29 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 6.5 | $20M | 330k | 60.39 | |
| Axsome Therapeutics (AXSM) | 4.3 | $13M | 165k | 79.59 | |
| Biohaven (BHVN) | 3.8 | $12M | 275k | 42.80 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $9.6M | 100k | 96.43 | |
| Cytokinetics Com New (CYTK) | 2.5 | $7.5M | 90k | 83.49 | |
| Ambrx Biopharma | 2.2 | $6.8M | 475k | 14.24 | |
| Roivant Sciences SHS (ROIV) | 2.2 | $6.7M | 600k | 11.23 | |
| Miragen Therapeutics (VRDN) | 2.1 | $6.5M | 300k | 21.78 | |
| Krystal Biotech (KRYS) | 2.0 | $6.2M | 50k | 124.06 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.0 | $6.1M | 150k | 40.76 | |
| Tarsus Pharmaceuticals (TARS) | 2.0 | $6.1M | 300k | 20.25 | |
| Apellis Pharmaceuticals Call Option (APLS) | 2.0 | $6.0M | 100k | 59.86 | |
| Argenx Se Sponsored Adr (ARGX) | 1.9 | $5.7M | 15k | 380.43 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $5.3M | 28k | 191.41 | |
| Bridgebio Pharma (BBIO) | 1.6 | $5.0M | 125k | 40.37 | |
| Aerovate Therapeutics (AVTE) | 1.6 | $4.8M | 210k | 22.63 | |
| Soleno Therapeutics (SLNO) | 1.5 | $4.5M | 112k | 40.25 | |
| Vaxcyte (PCVX) | 1.4 | $4.4M | 70k | 62.80 | |
| Tg Therapeutics (TGTX) | 1.4 | $4.3M | 250k | 17.08 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.2 | $3.8M | 165k | 23.11 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.2 | $3.7M | 2.1M | 1.77 | |
| Deciphera Pharmaceuticals | 1.2 | $3.6M | 225k | 16.13 | |
| Savara (SVRA) | 1.2 | $3.5M | 750k | 4.70 | |
| Phathom Pharmaceuticals (PHAT) | 1.1 | $3.5M | 385k | 9.13 | |
| Madrigal Pharmaceuticals (MDGL) | 1.1 | $3.5M | 15k | 231.38 | |
| Cabaletta Bio (CABA) | 1.1 | $3.4M | 150k | 22.70 | |
| Replimune Group (REPL) | 1.1 | $3.4M | 400k | 8.43 | |
| Revance Therapeutics (RVNC) | 1.1 | $3.3M | 375k | 8.79 | |
| Amylyx Pharmaceuticals Call Option (AMLX) | 1.0 | $2.9M | 200k | 14.72 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $2.9M | 125k | 22.93 | |
| Astria Therapeutics (ATXS) | 0.8 | $2.6M | 335k | 7.68 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $2.5M | 20k | 125.95 | |
| Arvinas Ord (ARVN) | 0.8 | $2.4M | 59k | 41.16 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $2.3M | 65k | 35.58 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $2.2M | 725k | 3.10 | |
| Natera (NTRA) | 0.7 | $2.2M | 35k | 62.64 | |
| Revolution Medicines Put Option (RVMD) | 0.7 | $2.2M | 75k | 28.68 | |
| Cymabay Therapeutics | 0.7 | $2.1M | 90k | 23.62 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $1.6M | 130k | 12.25 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $1.6M | 50k | 31.31 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.5 | $1.5M | 135k | 10.87 | |
| Inhibrx | 0.4 | $1.3M | 35k | 38.00 | |
| Cogent Biosciences (COGT) | 0.4 | $1.1M | 195k | 5.88 | |
| Uniqure Nv SHS (QURE) | 0.4 | $1.1M | 165k | 6.77 | |
| IsoRay | 0.2 | $643k | 1.6M | 0.40 | |
| Bluebird Bio (BLUE) | 0.2 | $642k | 465k | 1.38 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $596k | 30k | 19.88 |
